Eun Jin Lee

Title: Eun Jin Lee - Innovator in Dual-Target Antibody Development

Introduction

Eun Jin Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of dual-target antibodies. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Eun Jin Lee holds 2 patents related to his groundbreaking research. His latest patents include a dual-target antibody that specifically targets VEGFR-2 and DLL4. This invention encompasses a novel form of the antibody, a gene encoding the same, a recombinant expression vector that includes the gene, and host cells transformed with this vector. Additionally, the patent details a method for producing the dual-target antibody using these host cells, along with a pharmaceutical composition that comprises the dual-target antibody.

Career Highlights

Eun Jin Lee is currently associated with Pharmabcine Inc., where he continues to push the boundaries of antibody research. His work is instrumental in developing therapies that could potentially improve treatment outcomes for various diseases.

Collaborations

Eun Jin Lee collaborates with talented individuals in his field, including Joong Kyu Kim and Jin San Yoo. These partnerships enhance the innovative capacity of his research and contribute to the success of their projects.

Conclusion

Eun Jin Lee's contributions to the field of biotechnology, particularly through his dual-target antibody inventions, highlight his role as a leading inventor. His work at Pharmabcine Inc. and collaborations with esteemed colleagues further emphasize his commitment to advancing medical science.